The Claim
Among adults with obesity prescribed semaglutide in a real-world setting, 64% achieved at least 10% weight loss and 41% achieved at least 15% weight loss after 12 months of treatment.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In a group of adults with obesity who were given the medication semaglutide, 64% lost at least 10% of their body weight and 41% lost at least 15% after one year of treatment.
See the scientific wording
In a real-world cohort of adults with obesity prescribed semaglutide, 64% achieved at least 10% weight loss and 41% achieved at least 15% weight loss after 12 months, indicating a clinically meaningful proportion of patients respond substantially to this treatment.
Semaglutide tricks the body into feeling full faster and for longer by mimicking a natural hormone that tells the brain when to stop eating. It also slows down how fast food leaves the stomach, so people feel full longer and eat less.
What the research says
1 studyStudy: Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study
In a real-world study, over half of adults with obesity who took semaglutide for a year lost at least 10% of their body weight, and nearly half lost 15% or more — exactly what the claim says. This shows the medicine works well for many people.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.